0001209191-22-017592.txt : 20220309
0001209191-22-017592.hdr.sgml : 20220309
20220309163331
ACCESSION NUMBER: 0001209191-22-017592
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220110
FILED AS OF DATE: 20220309
DATE AS OF CHANGE: 20220309
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bandari Jathin
CENTRAL INDEX KEY: 0001903622
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36694
FILM NUMBER: 22725814
MAIL ADDRESS:
STREET 1: C/O PROTORA THERAPEUTICS, INC.
STREET 2: 345 PARK AVENUE SOUTH, 3RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10010
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Protara Therapeutics, Inc.
CENTRAL INDEX KEY: 0001359931
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 204580525
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 345 PARK AVENUE SOUTH
STREET 2: 3RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10010
BUSINESS PHONE: 646-844-0337
MAIL ADDRESS:
STREET 1: 345 PARK AVENUE SOUTH
STREET 2: 3RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10010
FORMER COMPANY:
FORMER CONFORMED NAME: ArTara Therapeutics, Inc.
DATE OF NAME CHANGE: 20200110
FORMER COMPANY:
FORMER CONFORMED NAME: PROTEON THERAPEUTICS INC
DATE OF NAME CHANGE: 20060420
4/A
1
doc4a.xml
FORM 4/A SUBMISSION
X0306
4/A
2022-01-10
2022-01-12
0
0001359931
Protara Therapeutics, Inc.
TARA
0001903622
Bandari Jathin
C/O PROTARA THERAPEUTICS, INC.
345 PARK AVENUE SOUTH, 3RD FLOOR
NEW YORK
NY
10010
0
1
0
0
Chief Medical Officer
Common Stock
21000
D
On January 12, 2022, the Reporting Person filed a Form 4 which inadvertently reported that, following the issuance of a restricted stock unit award, he directly owned 13,500 shares of the Issuer's common stock. In fact, as reported in this amendment, the Reporting Person directly owned 21,000 shares of common stock.
/s/ Mary Grendell, Attorney-in-Fact
2022-03-09